je.st
news
Tag: secondquarter
Merck Announces Second-Quarter 2015 Financial Results
2015-07-28 13:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Second-Quarter 2015 Non-GAAP EPS of $0.86, Excluding Certain Items; GAAP EPS of $0.24 Company Narrows and Raises 2015 Full-Year Non-GAAP EPS Target to $3.45 to $3.55, Excluding Certain Items; Lowers 2015 Full-Year GAAP EPS Target to $1.52 to $1.71 Second-Quarter 2015 Worldwide Sales Were $9.8 Billion, a Decrease of 11 Percent, Including a 7 Percent Net Unfavorable Impact from Acquisitions and Divestitures and a 7 Percent Negative Impact from Foreign Exchange Second-Quarter Results Reflect Sales Growth in Hospital Acute Care, Oncology and Diabetes and Sales Declines in Cardiovascular and Hepatitis C European Commission Approved KEYTRUDA for the Treatment of Advanced Melanoma; FDA Accepted sBLA for KEYTRUDA in Advanced Non-Small Cell Lung Cancer Grazoprevir/Elbasvir Chronic Hepatitis C Combination Regimen Accepted for Regulatory Review in Both the United States and European Union KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2015. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036Steven Cragle, 908-740-1801orInvestors:Justin Holko, 908-740-1879Joe Romanelli, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Encana Corp. posts second-quarter loss, revenue falls from year ago
2015-07-24 16:22:32| Energy - Topix.net
Encana Corp. reported a loss in its latest quarter as its U.S. operations were hit by a big impairment charge related to the drop in commodity prices. The company, which keeps its books in U.S. dollars, says its loss attributable to shareholders totalled US$1.61 billion or $1.91 per share for the quarter ended June 30. The loss for the quarter included an after-tax $1.33-billion impairment charge as well as a $187-million after-tax hit related to an unrealized hedging loss.
Encana Corp. posts second-quarter loss, revenue falls from year ago
2015-07-24 14:38:34| Oil & Gas - Topix.net
Encana Corp. reported a loss in its latest quarter as its U.S. operations were hit by a big impairment charge related to the drop in commodity prices. The company, which keeps its books in U.S. dollars, says its loss attributable to shareholders totalled US$1.61 billion or $1.91 per share for the quarter ended June 30. The loss for the quarter included an after-tax $1.33-billion impairment charge as well as a $187-million after-tax hit related to an unrealized hedging loss.
Valeant Pharmaceuticals posts second-quarter loss, sales up from year ago
2015-07-23 15:18:16| Biotech - Topix.net
Valeant Pharmaceuticals International Inc. raised its financial outlook for the year as it reported a loss in its latest quarter. The drug company says it now expects revenue this year to total between $10.7 billion to $11.1 billion, up from its earlier guidance for between $10.4 billion and $10.6 billion.
Cabot Oil & Gas Belongs In Your Portfolio Ahead of Second-Quarter Earnings
2015-07-23 14:39:05| Oil & Gas - Topix.net
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 9+ You may proceed to the site by clicking here , however some pages might not work correctly.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »